Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

56.67
+0.34000.60%
Pre-market: 56.30-0.3700-0.65%09:00 EDT
Volume:2.00M
Turnover:114.07M
Market Cap:7.93B
PE:38.42
High:58.64
Open:57.16
Low:56.24
Close:56.33
52wk High:76.76
52wk Low:9.57
Shares:140.01M
Float Shares:120.00M
Volume Ratio:0.70
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.48
EPS(LYR):-0.0122
ROE:75.50%
ROA:14.35%
PB:13.96
PE(LYR):-4,647.75

Loading ...

Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 14, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 10, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 27, 2021

Major Issues Report

ARROWHEAD PHARMACEUTICALS, INC.
Jun 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 22, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 04, 2021

Major Issues Report

8-K - Current report
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 23, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 23, 2020

Major Issues Report

8-K - Current report
Oct 09, 2020

Major Issues Report

8-K - Current report